>> Black Swan Analysis Blog

Black Swan Analysis Blog

QUANTIFYING THE MARKET POTENTIAL FOR A NEW PHARMACEUTICAL GRADE DIAGNOSTIC IMAGING AGENT

On November 22, 2017, Tags Case Studies

Brief

There is currently no industry standard database for Europe that identifies the location of PET/CT imaging sites and potential commercial cyclotron manufacturing sites. Unlike the US, the...

PAN-EUROPEAN STANDARDISATION OF FORECASTING PLATFORM

On November 22, 2017, Tags Case Studies

Brief

A global biopharmaceutical company is seeking to standardise the forecasting approach used in their core European markets. There is currently no consistent format, structure or coverage across...

ASIAN MARKET EXPANSION FOR NEW INFECTIOUS DISEASE TREATMENT

On November 22, 2017, Tags Case Studies

Brief

A global biopharmaceutical company is currently seeking approval to launch a new drug in several Asian countries for the treatment of a chronic, and endemic, infectious disease. Many of these...

CONCEPT TESTING OF AN INNOVATIVE IMAGING PLATFORM

On November 22, 2017, Tags Case Studies

Brief

A market leading device manufacturer is in the process of developing the next generation of imaging technology. The designs are currently at a conceptual stage with the product profile being...

PATIENT-BASED MODEL TO CHALLENGE PRE-EXISTING EVALUATION OF A NOVEL THERAPEUTIC FOR A POPULATION WITH HIGH UNMET MEDICAL NEED

On November 22, 2017, Tags Case Studies

Brief

A global biotechnology company had previously assessed the potential acquisition of a product with a novel mechanism of action, for use within a niche population with high unmet medical need....

Avid Radiopharmaceuticals, Vice-President Sales & Marketing - Testimonial

On November 20, 2017, Tags Testimonial
“I was really impressed by the work that Black Swan had produced for us. They quickly understood the complexity of the opportunity our product could deliver, carried out a thorough analysis and...

Gilead Sciences, International Commercial Strategy - Testimonial

On November 20, 2017, Tags Testimonial
“Black Swan helped our company to not only map out the patient journey, but identified leverage points for change. It was a logical user-friendly model interface which utilised all available data...

Amgen, Senior Health Economist - Testimonial

On November 20, 2017, Tags Testimonial
“The Black Swan Analysis team produced high quality models for several health economic projects. Their work is very methodical and based on a thorough analysis and interpretation of the available...

University of Manchester Intellectual Property, Venture Manager, Life Sciences and Medical & Human Sciences - Testimonial

On November 20, 2017, Tags Testimonial
“We were very impressed with the work conducted by Black Swan for us and it has set a new standard of asset valuation for our investors.”

Global Pharmaceutical Company, Director of Business Intelligence - Testimonial

On November 20, 2017,
“A highly intelligent group, yet friendly and accessible. The whole team is professional and innovative and they produce excellent work. You can trust that they will do the job that is required, not...
New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic